chrisvoncsefalvay/vaers-outcomes huggingface dataset:
12-03-2021 3:13 PM:  I spoke with patient she received her Pfizer booster on Wednesday and this is the progression of the reaction she had , Please review all 5 pictures and advise , She is currently on an antibiotic for sinusitis. Her skin as she described was like she had gotten burnt and started to peel. (pin to top) 12-03-2021 5:31 PM: called patient- rest of her skin outside of injection area has remained normal.  patient informed that VAERS system report is needed.  patient consents.  Denies that any expansion of blistered and peeling area.  Induration is also not spreading.  patient already on Augmentin for sinusitis.  She denies fever, chills, facial rash or swelling, SOB, or sensation of throat closing. ER precautions for Steven-Johnson's syndrome, anaphylaxis or worsening angioedema reviewed.  advised patient keep petrolatum and sterile gauze on base of blister until healed. Will call patient on 12/6 to check on condition (pin to top) 12-06-2021 3:08 PM: called patient.  patient reports pain, "yucky" appearance to blister, and went to dr. office.  patient denies spread of reaction beyond right arm, however patient has new sensation discrepancy between forearms.   patient significantly distressed by pain in reaction site, feels like pins and needles.   patient denies SOB, fever, dyspnea, expanding redness, nausea.  reviewed with patient that symptoms appear related to superficial irritation of nerves, similar to burn victims.   patient would like call back on 12/10/21 to follow symptoms (pin to top) 12-06-2021 3:25 PM :patient gives verbal consent to send in patient's pictures to VAERS system (pin to top) 12-10-2021 5:38 PM: called patient for update: -remains in pain -patient has kept arm covered up until yesterday was continuing to have goey granulation tissue -pain radiates down the arm (dorsal and ventral) and up to shoulder, but not into neck -blistered, desquamated area is same size -no border of redness has spread away from the blister -icing did not help the welt that formed before the blister  12-16-2021 1:33 PM: patient has not showed to visit or answered call today
f/u to caller. pt had facial and throat swelling , coughing, voice changes, went to er 1.5 hour after vaccine and was obs for 4 hours sx resolved today. has sore arm today er gave her epi pen , no drugs in the er  not a reason to avoid next vaccine but talk to your PCP..he might premedicate you.
10 minutes I got the shot my right arm became puffy, red, swollen and lasted one month. My arm swell up to a grapefruit size, was puffy and hot and was painful. I called my doctor, they said just keep an eye on it. After a month it went away, but I still have a small lump that is barely noticeable.
Donor became pale, light headed and nauseated. BP dropped 94/39, P 31. He was seated with legs elevated. Cold compress applied.
Lymph node (under armpit) tenderness; swelling; very mild pain; This is a spontaneous report from a contactable consumer. This 38-year-old female consumer (patient) reported that.   A 38-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: ER8730), dose 2 via an unspecified route of administration, administered in Arm Left on 02Apr2021 12:30 as (At the age of 38-years) dose 2, single for covid-19 immunisation. Medical history included, Mild Hypertension, and seasonal allergies from an unknown date and unknown if ongoing. List of any other medications the patient received within 2 weeks of vaccination included Losartan, Montelukast, Hydrochlorothiazide, cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) all are taken for an unspecified indication, start and stop date were not reported. Patient was not diagnosed with COVID-19 Prior to vaccination. Patient was not tested for COVID-19 Since the vaccination. No Allergies to medications, food, or other products were reported. Patient was not pregnant at the time of vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6207), dose 1 via an unspecified route of administration, administered in Arm Left on 12Mar2021 12:30 PM as dose 1, single for covid-19 immunisation. The patient experienced lymph node (under armpit) tenderness, swelling, and very mild pain on 04Apr2021 03:00. Patient did not receive any tenement for events. The outcome of event was not recovered.  information about lot/batch number is available.  No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. On 21-SEP-2013 the patient was vaccinated with ZOSTAVAX (strength, dose, frequency, route and lot# were not provided). The patient developed a large blue/purple Hematome on the Monday 23-SEP-2013. The patient consulted a physician (date unspecified) and was diagnosed as to having a reaction to the ZOSTAVAX. The outcome of event was unknown. Additional information has been requested.
Nine days post vaccine I noticed redness, swelling, itchiness and mild pain at injection site.
Felt like she had a fever; muscle weakness; headache; myalgia; fatigue; shivering; Skin was painful; Skin was painful and burning to the touch; gastrointestinal upset; pain around injection site; Right deltoid was swollen; Right deltoid was red; Right deltoid was warm; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 57-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 20th October 2020, the patient received the 1st dose of Shingrix (intramuscular). On 23rd October 2020, 3 days after receiving Shingrix, the patient experienced injection site pain, muscle swelling, localized erythema and localized feeling of warmth. On 27th October 2020, the patient experienced muscle weakness, headache, myalgia, fatigue, shivering, skin pain, burning skin and gastrointestinal upset. On 28th October 2020, the patient experienced fever. On an unknown date, the outcome of the injection site pain, muscle swelling, localized erythema and localized feeling of warmth were recovered/resolved and the outcome of the muscle weakness, headache, myalgia, fatigue, shivering, skin pain, burning skin and gastrointestinal upset were not recovered/not resolved and the outcome of the fever was unknown.   It was unknown if the reporter considered the injection site pain, muscle swelling, localized erythema, localized feeling of warmth, muscle weakness, headache, myalgia, fatigue, shivering, skin pain, burning skin, gastrointestinal upset and fever to be related to Shingrix.   Additional details were provided as follows: The patient received Shingrix in the right arm. The patient reported on day 3 after receiving the vaccine, her right deltoid was swollen, right deltoid was red, right deltoid was warm, and pain around the injection site. The patient reported these events had resolved by day 5 after receiving the vaccine. The patient reported on day 7 after receiving the vaccine had headache, myalgia, fatigue, shivering, gastrointestinal upset, muscle weakness and skin was painful and burning to the touch and all of these were still ongoing at this time.  The patient reported last night (28th October 2020), she felt like she had a fever and she took her temperature and it was 98.6 degree F. The reporter consented to follow up and did not have lot number or expiration date information to provide.
Pfizer-BioNTech COVID-19 Vaccine EUA. //Symptoms began 12 hours after with increase soreness at injection site radiating up and down arm and up into neck ; Body aches especially lower back developed within 24 hours with a severe throbbing type headache and ringing in the ears. Elevation of temperature by 1-2 degrees normal for me runs 97 degrees F and was up to 99 degrees F. Headache intensified with movement(ex. .bending over ,etc) Treated arm soreness and lower back with heat compresses...  elevated temp and headache with rest and a lot of water. It is now over 48 hours since vaccination and all symptoms are subsiding but still present with temperature normal for me and no arm soreness. Scheduled day off from work day after vaccination but also a second day due to the severe headache mostly.
Received Fluarix vaccine in left deltoid (lot # AFLUA356AA exp date 5/31/09 at approx 04:30 this am.  States approx 15min later noted pain into neck and radiating down left arm; approx 4 hours later noted raised bumps on both forearms; approx 15 min later petichiae on left arm distal to elbow;  approximately 45 min later noticed progression of numbness into jaw, mouth, head.  Sent to Emergency Room.  Previously received Fluarix in 2005 & 2006 with no adverse reaction.
Overall weakness, dizzy, BP became low when standing, chills  Clindamycin 5 days - unknown dosage , chest x ray 04/13/21 states her antibiotics were changes and had her x-ray today pending results. reports she is chronically dehydrated and has orthostatic hypotension. recommended she stay well hydrated if not restricted on fluid intake caller verbalized understanding. Q99- asked if the vaccine causes a lupus or RA flare up?
Patient was administered Boostrix as documented above. Mom reports he has been more anxious from Jan-Feb 2020, wonders if it's related. No other concerning symptoms. I told her I don't think it's related.
Headache, Myalgia, Fever, chills, h/a fever, body aches Narrative:
FEVER, DIZZINESS, HEADACHES X 4 DAYS STARTING ON 6/18/2010 THRU 6/22/2010 AND ALSO ON 6/24/2010 STARTED WITH RASH THRU PRESENT (6/27/2010). IT HAS WORSENED AND LOOK MORE LIKE HIVES ON ARMS, LEGS, THIGHS, AND STOMACH AREA.
soon after receiving vaccine my lips were tingling then within an hour the left side of my face was numb - like I had novocaine.  The shot was given to me in my right arm - lasted a few hours and then was gone
Rash & Fever - went to ED. + burning &  itching on back. Joint pain in fingers, joint pain rt elbow and wrist. Pain soles of feet. Started one week prior to 5/31/21. Dx'd with macular rash. Elevated C-reactive protein. Elevated sed. rate. Arthraligia of both hands. (Date of visit 5/31/21)
This spontaneous report as received from a medical assistant regarding a patient of unknown age and gender. Information on the concurrent condition, medical history and pertinent drug allergies of the patient were not reported. On 14-OCT-2015 the patient was vaccinated with improperly stored  RECOMBIVAX HB (lot # L004754, expiry date-10-NOV-2016)(dose #, route, dose units and anatomical location were not specified). Concomitant medication was not reported. No adverse events were reported. There were no Product Quality Complaint (PQC) involved. This is one of several reports received from the same reporter. Additional information has been requested.
Severe headache, extreme muscular weakness, joint pain, extreme fatigue, nausea for about 40 hours. Fatigue another 8 hours.  Could not work or even read.  Redness on left upper arm, 4 to 5 inches vertically and wrapping around  the outer half. Also  extending to armpit, Swelling and pain of same area, more painful with movement or pressure. Has not diminished at this point 12:17AM 3/1/2020 So mostly recovered but not entirely.
been having sleeping problems ever since my first dose of Moderna/ Every night over the last 3 weeks I am waking up between 1230-4am far a little bit; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (been having sleeping problems ever since my first dose of Moderna/ Every night over the last 3 weeks I am waking up between 1230-4am far a little bit) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INSOMNIA (been having sleeping problems ever since my first dose of Moderna/ Every night over the last 3 weeks I am waking up between 1230-4am far a little bit). At the time of the report, INSOMNIA (been having sleeping problems ever since my first dose of Moderna/ Every night over the last 3 weeks I am waking up between 1230-4am far a little bit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported. No treatment medication were reported.
This spontaneous report was received from a registered nurse refers to a patient of unknown age and gender. Patient medical history and current condition was not reported. On 16-APR-2015 the patient was vaccinated with ROTATEQ oral liquid (unknown dose and Lot number) orally which underwent supported temperature excursions. Reporter stated that since 8-APR-2015, the doses of ROTATEQ underwent supported temperature excursions. No adverse effects reported. The outcome of the event was unknown. This is one of the 5 reports received from the same reporter. Additional information has been requested.
Patient had a tonic clonic seizure lasting approx 1 minute. No illness or injury before the seizure. He slept for the hour drive to the hospital and woke up with no memory of the incident and felt fine. Tests at the hospital were normal. He will have an ECG and neurology follow up. No hx of seizure with him or in the family. EEG on 10/28.
Ache: joints, ache: joints and muscles, acid reflux, Amnesia, bladder problems, vision problems, blood pressure high, blood high cholesterol, concentration difficulty and loss of concentration, dermatitis, digestive problems nausea, gastritis, headaches, hemorrhoids, impotence, incontinence urinary, sleep insomnia, libido loss, memory difficulty and loss, memory short-term loss, anxious, irritable, nasal runny nose, nervousness, lower back pain, groin pain, knees and hips pain, stomach problems, verbal skills problems, trouble finding words, vision problems.
This case was reported by a physician via call center representative and described the occurrence of redness of legs in a adult female patient who received FLUARIX QUADRIVALENT 2019-2020 season) for prophylaxis. On an unknown date, the patient received FLUARIX QUADRIVALENT 2019-2020 season. On an unknown date, less than a year after receiving FLUARIX QUADRIVALENT 2019-2020 season, the patient experienced redness of legs. On an unknown date, the outcome of the redness of legs was recovered/resolved. It was unknown if the reporter considered the redness of legs to be related to FLUARIX QUADRIVALENT 2019-2020 season. Additional details were reported as follows: The age at vaccination was not reported. Last year, the patient developed erythema bilaterally in both legs after a dose of FLAURIX which resolved after 14 days. The reporter consented to follow up. Sender's Comments:  US-GLAXOSMITHKLINE-US2020202326: Same reporter.
3-4 weeks after the vaccination I developed a ovarian vein thrombosis and was hospitalized on 3/15/21 .  I am concerned  based on new reports of blood clots in women with the Johnson & Johnson vaccination that this is related to my first injection.   I was a healthy individual prior to this with no history of blood clots.
I broke out in hives within a day of getting the vaccine. These hives were mainly on the back of my thigh, buttocks and wrists. They persisted for about 3 days and I still have the residual bump but are no longer itchy.
No additional AE reported; PROQUAD had expired on 2/7/2022 and was administered to a patient on 2/18/2022.; This spontaneous report was received from a certified medical assistant and refers to a 4-year-old male patient. No information regarding the patient's pertinent medical history, concomitant medications and drug reactions or allergies was reported.   On 18-FEB-2022, the patient the patient was vaccinated with an expired dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (albumin status rHA) (PROQUAD) lot #T027116 was confirmed to be valid, expiration date: 07-FEB-2022, administered for prophylaxis (exact dose, route of administration, anatomical location were not reported). No adverse effects were reported.
pt was given APAP p/vax-went to sleep woke up 630PM (approx 4 hrs p/vax) very pale & listless, lips sl blue; seemed to have difficulty swallowing, kept sticking tongue out; would not open eyes; episode lasted 5 mins; t98.7; MD notified;
Baby's legs turned bright red from thighs to toes. No breathing problems or SOB.
ENGERIX-B pediatric administered to Adult; ENGERIX-B pediatric administered to Adult; This case was reported by a nurse via other manufacturer and described the occurrence of adult use of a child product in a adult patient who received HBV (Engerix B pediatric) for prophylaxis.   On an unknown date, the patient received Engerix B pediatric. On an unknown date, unknown after receiving Engerix B pediatric, the patient experienced adult use of a child product and underdose. On an unknown date, the outcome of the adult use of a child product and underdose were unknown.    Additional Information: GSK Receipt Date: 24-AUG-2022.  Reporter's Comments: The reporter stated that, the adult patient was administered Engerix B pediatric dose on unknown, previous date.  The reporter was unable further clarify the statement. No additional adverse event (AE) reported. No product quality complain (PQC) reported.  Additional Supportive Information: As adult patient received Engerix B pediatric dose, which led to adult use of a child product and underdose.
Patient's  representative contacted the pharmacy to inform us  that 30 minutes after leaving the store post vaccine the patient experienced and seizure and was taken in to seen and was later sent home . We have informed patient's primary care physician.
felt a little bit bad not as bad as after the second one; really severe chills; really severe body aches, it was pretty intense, it knocked them out; This spontaneous case was reported by a pharmacist and describes the occurrence of FEELING ABNORMAL (felt a little bit bad not as bad as after the second one), CHILLS (really severe chills) and MYALGIA (really severe body aches, it was pretty intense, it knocked them out) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 032L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (felt a little bit bad not as bad as after the second one), CHILLS (really severe chills) and MYALGIA (really severe body aches, it was pretty intense, it knocked them out). At the time of the report, FEELING ABNORMAL (felt a little bit bad not as bad as after the second one) outcome was unknown and CHILLS (really severe chills) and MYALGIA (really severe body aches, it was pretty intense, it knocked them out) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided by reporter. No treatment information was provided by reporter.   This case was linked to MOD-2022-455269, MOD-2022-455278, MOD-2022-455207, MOD-2022-455209 (Patient Link).
Patient complained about feeling lightheaded and nauseous. EMT called. Vitals BP 76/53 HR 63 O2 sat 99% and blood sugar 112. Per patient's mom, that is his normal vitals. Patient given water and laid down in ambulance. Patient refused EMT accompany to hospital and states he is feeling better.
Patient presents with ? Shortness of Breath     worsening today     HPI  There is a 66-year-old female with a history of COPD on 2.5 L chronically that presents to the emergency department for complaint of shortness of breath as well as epigastric pain.  Onset of symptoms within the past several weeks.  She notes that her epigastric pain was never "addressed".  Additionally, she notes that she frequently has COPD exacerbations.  She is on her baseline home O2 requirements.  Patient denies any fevers, chills, runny nose or chest pain.  Epigastric abdominal pain is described as stabbing in nature.  Reports normal eating and bowel pattern.   Review of Systems  Constitutional: Positive for fatigue. Negative for chills and fever.  HENT: Negative for facial swelling and trouble swallowing.   Respiratory: Positive for shortness of breath. Negative for cough and wheezing.   Cardiovascular: Negative for chest pain and palpitations.  Gastrointestinal: Positive for abdominal pain (epigastric). Negative for diarrhea, nausea and vomiting.  Genitourinary: Negative for dysuria and frequency.  Musculoskeletal: Negative for back pain and neck pain.  Skin: Negative for rash and wound.  Neurological: Negative for weakness, light-headedness and headaches.  Psychiatric/Behavioral: Negative for confusion. The patient is not nervous/anxious
FATIGUE; BODY ACHES; HEART PALPITATIONS; LOW GRADE; This spontaneous report received from a patient concerned a 63 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included g6pd deficiency.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805025, and expiry: UNKNOWN) dose was not reported, administered on 27-MAR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported. On 28-MAR-2021, the subject experienced body aches. On 28-MAR-2021, the subject experienced heart palpitations. On 28-MAR-2021, the subject experienced low grade. On 29-MAR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, heart palpitations, low grade, and fatigue on 2021. This report was non-serious.
Side effects after the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Side effects after the vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (Side effects after the vaccine). At the time of the report, ADVERSE EVENT (Side effects after the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.